Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist
Phase 2 Study of IL-1Ra in Patients With Type 2 Diabetes
Sponsor: Steno Diabetes Center Copenhagen
A PHASE2 clinical study on Type 2 Diabetes, this trial is completed. The trial is conducted by Steno Diabetes Center Copenhagen and has accumulated 7 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2019 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Apr 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Steno Diabetes Center Copenhagen
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .